A myelin-specific contrast agent for magnetic resonance imaging of myelination.
Myelination is one of the most fundamental biological processes in the development of vertebrate nervous systems. Abnormal or disrupted myelination occurs in many acquired or inherited neurodegenerative diseases, including multiple sclerosis (MS) and various leukodystrophies. To date, magnetic resonance imaging (MRI) has been the primary tool for diagnosing and monitoring the progression of MS and related diseases; however, any change in signal intensity of conventional MRI reflects a change only in tissue water content, which is a nonspecific measure of the overall changes in macroscopic tissue injury. Thus, the use of MRI as a primary measure of disease activity was shown to be disassociated from the clinical outcome due to the lack of specificity for myelination. In order to increase the MRI specificity for myelin pathologies, we designed and synthesized the first Gd-based T(1) MR contrast agent (MIC) that binds to myelin with high specificity. In this Communication, we demonstrate that MIC localizes in brain regions in proportion to the extent of myelination. In addition, MIC possesses promising MR contrast properties, which allow for direct detection of myelin distribution through T(1) mapping in the mouse brain.
Division of Radiopharmaceutical Science, Case Center for Imaging Research, Department of Radiology, Case Western Reserve University, Cleveland, Ohio 44106, United States.
Luca
L
Frullano
Changning
C
Wang
Robert H
RH
Miller
Yanming
Y
Wang
D000818:Animals; D001921:Brain / Q000166:cytology; D002462:Cell Membrane / Q000378:metabolism; D003287:Contrast Media / Q000138:chemical synthesis / Q000378:metabolism; D015195:Drug Design; D005682:Gadolinium / Q000737:chemistry; D008279:Magnetic Resonance Imaging / Q000379:methods*; D051379:Mice; D009186:Myelin Sheath / Q000378:metabolism / Q000502:physiology*
D003287:Contrast Media; D005682:Gadolinium
Prog Neurobiol. 1993 Mar;40(3):319-84
8441812
J Magn Reson Imaging. 2005 Jun;21(6):669-75
15906322
J Neurooncol. 2004 Jul;68(3):207-15
15332323
Lancet. 2002 Apr 6;359(9313):1221-31
11955556
Ann Neurol. 2005 Dec;58(6):840-6
16283615
J Magn Reson Imaging. 2001 Apr;13(4):534-46
11276097
Invest Radiol. 2005 Nov;40(11):715-24
16230904
J Neuroimmunol. 1992 Oct;40(2-3):139-52
1430147
Mult Scler. 2005 Feb;11(1):5-12
15732260
Nat Rev Neurosci. 2005 Sep;6(9):683-90
16136172
J Histochem Cytochem. 2010 Jul;58(7):611-21
20354147
Invest Radiol. 2001 Feb;36(2):115-22
11224760
Curr Opin Neurol. 2001 Dec;14(6):789-94
11723390
Neurology. 2001 Dec 26;57(12):2191-7
11756596
Neuroimage. 2002 Nov;17(3):1429-36
12414282
Neuroimage. 2009 Jun;46(2):382-93
19385012